LAVA Therapeutics
LVTX
LVTX
15 hedge funds and large institutions have $11.7M invested in LAVA Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
15
Holding in Top 10
–
Calls
$35K
Puts
–
Top Buyers
| 1 | +$203K | |
| 2 | +$163K | |
| 3 | +$30.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24.3K |
| 5 |
HF
HRT Financial
New York
|
+$21K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$375K | |
| 3 | -$233K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$88.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$53.5K |